# The Prevalence and Characteristics of Primary Headache and Dream-Enacting Behaviour in Japanese Patients with Narcolepsy or Idiopathic Hypersomnia: A Multi-Centre Cross-Sectional Study

**Authors:** Keisuke Suzuki, Masayuki Miyamoto, Tomoyuki Miyamoto, Yuichi Inoue, Kentaro Matsui, Shingo Nishida, Kenichi Hayashida, Akira Usui, Yoichiro Ueki, Masaki Nakamura, Momoyo Murata, Ayaka Numao, Yuji Watanabe, Shiho Suzuki, Koichi Hirata

PMC · DOI: 10.1371/journal.pone.0139229 · PLoS ONE · 2015-09-29

## TL;DR

This study finds that headaches, especially migraines, are more common in Japanese patients with narcolepsy and idiopathic hypersomnia compared to healthy individuals, and that dream-enacting behavior is a notable feature in narcolepsy.

## Contribution

The study provides new insights into the prevalence and characteristics of primary headaches and dream-enacting behavior in Japanese patients with narcolepsy and idiopathic hypersomnia.

## Key findings

- Migraine prevalence was significantly higher in narcolepsy and idiopathic hypersomnia patients compared to healthy controls.
- Narcolepsy patients with migraines showed more excessive daytime sleepiness than those without headaches.
- Dream-enacting behavior was more common in narcolepsy patients than in idiopathic hypersomnia patients and healthy controls.

## Abstract

Because the prevalence and characteristics of primary headache have yet to be thoroughly studied in patients with hypersomnia disorders, including narcolepsy and idiopathic hypersomnia, we examined these parameters in the Japanese population.

In a multicentre cross-sectional survey, among 576 consecutive outpatients with sleep disorders, 68 narcolepsy patients and 35 idiopathic hypersomnia patients were included. Additionally, 61 healthy control subjects participated. Semi-structured headache questionnaires were administered to all participants.

The patients with narcolepsy (52.9%) and idiopathic hypersomnia (77.1%) more frequently experienced headache than the healthy controls (24.6%; p<0.0001). The prevalence rates were 23.5%, 41.2% and 4.9% for migraine (p<0.0001) and 16.2%, 23.5% and 14.8% (p = 0.58) for tension-type headache among the narcolepsy patients, the idiopathic hypersomnia patients and the control subjects, respectively. Those who experienced migraine more frequently experienced excessive daytime sleepiness, defined as an Epworth Sleepiness Scale score of ≥10, than those who did not experience headache among the patients with narcolepsy (93.8% vs. 65.6%, p = 0.040) and idiopathic hypersomnia (86.7% vs. 37.5%, p = 0.026). Dream-enacting behaviour (DEB), as evaluated by the rapid eye movement sleep disorders questionnaire, was more frequently observed in the narcolepsy patients than in the idiopathic hypersomnia patients and the control subjects. An increased DEB frequency was observed in the narcolepsy patients with migraines compared to those without headache.

Migraines were frequently observed in patients with narcolepsy and idiopathic hypersomnia. DEB is a characteristic of narcolepsy patients. Further studies are required to assess the factors that contribute to migraines in narcolepsy and idiopathic hypersomnia patients.

## Linked entities

- **Diseases:** narcolepsy (MONDO:0021107), idiopathic hypersomnia (MONDO:0018044), migraine (MONDO:0005277)

## Full-text entities

- **Genes:** HCRT (hypocretin neuropeptide precursor) [NCBI Gene 3060] {aka NRCLP1, OX, PPOX}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1) [NCBI Gene 3119] {aka CELIAC1, HLA-DQB, IDDM1}
- **Diseases:** chronic pain (MESH:D059350), Headache Disorders (MESH:D020773), Migraines (MESH:D008881), aura (MESH:D004827), pain (MESH:D010146), sleep deprivation (MESH:D012892), Cataplexy (MESH:D002385), rapid eye movement sleep behaviour disorder (MESH:D020187), ICSD-3 (MESH:C537153), initiating (MESH:D007319), Narcolepsy (MESH:D009290), obstructive sleep apnea (MESH:D020181), neurogenic inflammation (MESH:D020078), DEB (MESH:D001523), narcolepsy type 1 and type 2 (MESH:C563534), apnoea-hypopnoea (MESH:D001049), medication-overuse headache (MESH:D051271), nociception (MESH:D059226), Headache (MESH:D006261), tension-type headache (MESH:D018781), obesity (MESH:D009765), hallucinations (MESH:D006212), restless legs syndrome (MESH:D012148), oxygen desaturation (MESH:D000860), periodic limb movement (MESH:D020189), metabolic syndrome (MESH:D024821), Daytime sleepiness (MESH:D012893), Depression (MESH:D003866), sleep apnoea (MESH:D012891), hypnic headache (MESH:D051270), occipital neuralgia (MESH:D009437), sleepiness (MESH:D000077260), Idiopathic Hypersomnia (MESH:D020177), EDS (MESH:D006970), migraine headaches without aura (MESH:D020325), Impaired quality of life (MESH:D003643), cluster headache (MESH:D003027), sleep paralysis (MESH:D020188)
- **Chemicals:** triptans (MESH:D014363), Histamine (MESH:D006632), anti (-), KCl (MESH:D011189)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4587931/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4587931/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC4587931/full.md

---
Source: https://tomesphere.com/paper/PMC4587931